<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000306516">
  <TermName>SGN-00101</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the prevention of cancer. It belongs to the family of drugs called fusion proteins.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>SGN-00101</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para la prevención del cáncer. Es un tipo de proteína de fusión.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-05-23</DateFirstPublished>
  <DateLastModified>2003-06-26</DateLastModified>
</GlossaryTerm>
